The Research Working Group seeks to bridge the missing mile between basic research and the commercialization of products. Having an equal partnership between the Virtual Physiological Human Institute (VPH) and industries engaged in predictive medicine provides a unique opportunity to explore areas of mutual cooperation and benefit.
The key goals of this group are:
- Promotion of in silico medicine in Horizon 2020;
- Working towards the creation of a Public Private Partnership (PPP) on in silico medicine;
- Creating links between the VPH Membership and Avicenna Industry Members
Priorities in 2017
→ Contribute to the Avicenna Alliance Policy Recommendations on in silico medicine to be submitted to the European Commission;
→ Develop draft suggested Call Texts for proposals for the “Health, Demographic Change and Well-being” sections for Horizon 2020;